Jane Street Group, LLC Aldeyra Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$2.43 - $4.85 $55,161 - $110,094	-22,700 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$3.25 - $5.17 $179,400 - $285,384	-55,200 Reduced 70.86%	22,700 $101,000
Q4 2021 Feb 15, 2022	BUY	$3.5 - $9.63 $194,600 - $535,428	55,600 Added 249.33%	77,900 $312,000
Q3 2021 Nov 16, 2021	SELL	$7.94 - $11.31 $176,268 - $251,082	-22,200 Reduced 49.89%	22,300 $196,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $326,772 - $464,805	31,300 Added 237.12%	44,500 $504,000
Q1 2021 May 18, 2021	BUY	$6.53 - $14.42 $86,196 - $190,344	13,200 New	13,200 $157,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.